NCT04028596View on ClinicalTrials.gov

Measuring Blood Flow in the Brain After Epileptic Activity

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

April 15, 2023

Conditions
EpilepsyDepressionPostictal DeliriumElectroconvulsive Therapy
Interventions
DRUG

Paracetamol

once, 1000mg, 2 h before ECT session

DRUG

Nimotop

once, 60mg, 2 h before ECT session

Trial Locations (1)

6815 AD

Rijnstate Hospital, Arnhem

All Listed Sponsors
collaborator

University of Twente

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

Rijnstate Hospital

OTHER

NCT04028596 - Measuring Blood Flow in the Brain After Epileptic Activity | Biotech Hunter | Biotech Hunter